Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis.
Dimethyl fumarate : a Janus-faced substance?
Novel MRI and PET markers of neuroinflammation in multiple sclerosis.
Imaging and diagnostic criteria for Multiple Sclerosis: Are we there yet?
Vitamin D in multiple sclerosis: implications for assessment and treatment.
Fluctuations in appraisal over time in the context of stable versus non-stable health.
Cerebrospinal Venous Outflow in Multiple Sclerosis Patients versus Fatigue and/or Depression.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Oct4-induced oligodendrocyte progenitor cells enhance functional recovery in spinal cord injury model.
Low prevalence of human herpesvirus-6 and varicella zoster virus in blood of multiple sclerosis patients, irrespective of inflammatory status or disease progression.
Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
Use of Functional Ambulation Performance Score as measurement of gait ability: Review.
Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings.
Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes.
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Step-rate thresholds for physical activity intensity in persons with multiple sclerosis.
Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.
Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2.
Differential roles of resident microglia and infiltrating monocytes in murine CNS autoimmunity.
[Chronic cough and worsening dyspnea: a case of idiopathic tracheal stenosis].
The role of IL-17 in CNS diseases.
A Helminth Protease Inhibitor Modulates the Lipopolysaccharide-Induced Proinflammatory Phenotype of Microglia in vitro.
In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
Pages
« first
‹ previous
…
366
367
368
369
370
371
372
373
374
…
next ›
last »